<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1266888</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2023.1266888</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Research progress of calcium carbonate nanomaterials in cancer therapy: challenge and opportunity</article-title>
<alt-title alt-title-type="left-running-head">Liang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2023.1266888">10.3389/fbioe.2023.1266888</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Liang</surname>
<given-names>Tiantian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Feng</surname>
<given-names>Zongqi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1966912/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xiao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Tianfang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Tingyu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yu</surname>
<given-names>Lan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1857047/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Graduate School</institution>, <institution>Inner Mongolia Medical University</institution>, <addr-line>Hohhot</addr-line>, <addr-line>Inner Mongolia</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Clinical Medical Research Center</institution>, <institution>Inner Mongolia People&#x2019;s Hospital</institution>, <addr-line>Hohhot</addr-line>, <addr-line>Inner Mongolia</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Inner Mongolia Key Laboratory of Gene Regulation of the Metabolic Disease</institution>, <institution>Inner Mongolia People&#x2019;s Hospital</institution>, <addr-line>Hohhot</addr-line>, <addr-line>Inner Mongolia</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Inner Mongolia Academy of Medical Sciences</institution>, <institution>Inner Mongolia People&#x2019;s Hospital</institution>, <addr-line>Hohhot</addr-line>, <addr-line>Inner Mongolia</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1108088/overview">Hamed Barabadi</ext-link>, Shahid Beheshti University of Medical Sciences, Iran</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/642674/overview">Yilun Wu</ext-link>, The University of Queensland, Australia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1866715/overview">Chuang Liu</ext-link>, Harvard Medical School, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1143508/overview">Xuan Mei</ext-link>, Harvard Medical School, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Lan Yu, <email>yulan@imph.ac.cn</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1266888</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Liang, Feng, Zhang, Li, Yang and Yu.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Liang, Feng, Zhang, Li, Yang and Yu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Cancer has keeping the main threat to the health of human being. Its overall survival rate has shown rare substantial progress in spite of the improving diagnostic and treatment techniques for cancer in recent years. Indeed, such classic strategies for malignant tumor as surgery, radiation and chemotherapy have been developed and bring more hope to the patients, but still been accompanied by certain limitations, which include the challenge of managing large wound sizes, systemic toxic side effects, and harmful to the healthy tissues caused by imprecise alignment with tumors in radiotherapy. Furthermore, immunotherapy exhibits a limited therapeutic effect in advanced tumors which is reported only up to 25%&#x2013;30%. The combination of nanomaterials and cancer treatment offers new hope for cancer patients, demonstrating strong potential in the field of medical research. Among the extensively utilized nanomaterials, calcium carbonate nanomaterials (CCNM) exhibit a broad spectrum of biomedical applications due to their abundant availability, cost-effectiveness, and exceptional safety profile. CCNM have the potential to elevate intracellular Ca<sup>2&#x2b;</sup> levels in tumor cells, trigger the mitochondrial damage and ultimately lead to tumor cell death. Moreover, compared with other types of nanomaterials, CCNM exhibit remarkable advantages as delivery systems owing to their high loading capacity, biocompatibility and biodegradability. The purpose of this review is to provide an overview of CCNM synthesis, focusing on summarizing its diverse roles in cancer treatment and the benefits and challenges associated with CCNM in cancer therapy. Hoping to present the significance of CCNM as for the clinical application, and summarize information for the design of CCNM and other types of nanomaterials in the future.</p>
</abstract>
<kwd-group>
<kwd>calcium carbonate nanomaterials</kwd>
<kwd>nanotechnology</kwd>
<kwd>drug carrier</kwd>
<kwd>pH-responsive</kwd>
<kwd>cancer treatment</kwd>
</kwd-group>
<contract-num rid="cn001">No. 82160299</contract-num>
<contract-num rid="cn002">No. 2023LHMS08022</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Natural Science Foundation of Inner Mongolia<named-content content-type="fundref-id">10.13039/501100004763</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nanobiotechnology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Cancer is the second leading cause of mortality worldwide (<xref ref-type="bibr" rid="B74">Sung et al., 2021</xref>). According to data of 2020, there were 19.29 million new cancer cases worldwide, including 10.6 million males and 9.23 million females. Respectively, 5.53 million males and 4.43 million females die from cancer worldwide (<xref ref-type="bibr" rid="B89">Xia et al., 2022</xref>). Consequently, cancer has imposed a substantial economic burden on global healthcare systems. Surgery, chemotherapy and radiotherapy have been the classical cancer treatment. Surgery is the most efficient way to remove the solid tumor, however, incomplete resection and the possibility of helping the cancer cell metastasis during resection are the unavoidable problems (<xref ref-type="bibr" rid="B11">Curtis et al., 2020</xref>; <xref ref-type="bibr" rid="B92">Yamaguchi et al., 2021</xref>). Chemotherapy and radiotherapy bring fatal damage not only to the cancer cells, but the normal cells, let alone the drug resistance and the immunosuppression which is caused by the bone marrow damage (<xref ref-type="bibr" rid="B5">Behranvand et al., 2022</xref>). Furthermore, radiotherapy itself could cause cell unknown mutations and the metastasis (<xref ref-type="bibr" rid="B68">Ruysscher et al., 2019</xref>). In recent years, the emerging immunotherapy has received widespread attention due to its reasonable theory and the optimistic effects; whereas, the percentage of the patients who could benefit from it is comparatively low because of the significant heterogeneity of cancer (<xref ref-type="bibr" rid="B48">Liu et al., 2021</xref>). Nanomaterials have played an active role in the biomedical field, especially in cancer treatment (<xref ref-type="bibr" rid="B34">Kashyap et al., 2023</xref>; <xref ref-type="bibr" rid="B58">Pei et al., 2023</xref>). The inherent characteristics of the nanomaterial, such as particle size, atomic composition, magnetic and electronic specificity confer the nanoparticles with unparalleled advantages in treating diseases, particularly in targeting therapy for cancer (<xref ref-type="bibr" rid="B84">Wang et al., 2023a</xref>). By modifying nanoparticles in physical, chemical, and biological activity aspects, their dissolution is promoted, absorption is improved, and delivery efficiency is enhanced (<xref ref-type="bibr" rid="B107">Zhu and Li, 2023</xref>). The use of nanoparticles to control the delivery and release of anticancer drugs has become a hot topic in the research of nanocarrier drugs (<xref ref-type="bibr" rid="B94">Yang et al., 2022</xref>). Among numerous nanomaterials, calcium carbonate nanomaterials (CCNM) have distinctive properties: good biocompatibility, easily synthesized, and could be produced in diverse forms and crystal structures (<xref ref-type="bibr" rid="B50">Luo et al., 2020</xref>; <xref ref-type="bibr" rid="B41">Li et al., 2021a</xref>).</p>
<p>CCNM are widely used in various industries such as food packaging, pharmaceuticals, paint pigments, and polymer fillers (<xref ref-type="bibr" rid="B71">Shou et al., 2022</xref>). Meanwhile, it shows great potential in biomedicine, environmental remediation and energy production, etc. (<xref ref-type="fig" rid="F1">Figure 1</xref>). In biomedicine field, CCNM can be used in treating cancer, disease detection and bone regeneration (<xref ref-type="bibr" rid="B81">Vikulina et al., 2021</xref>). Due to the biocompatibility and high specific surface area of CCNM, they possess the remarkable advantages in drug delivery (<xref ref-type="bibr" rid="B53">Mao et al., 2021</xref>). CCNM could provide Ca<sup>2&#x2b;</sup>, attack mitochondria, and further kill malignant cells in cancer therapy (<xref ref-type="bibr" rid="B3">Bai et al., 2022</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Applications of CCNM in different fields.</p>
</caption>
<graphic xlink:href="fbioe-11-1266888-g001.tif"/>
</fig>
<p>In this review, we first reviewed the main synthesis methods of CCNM, followed by summarizing their different functions in cancer treatment, including drug carriers, synergistic therapy, Ca<sup>2&#x2b;</sup> overload therapy, etc. Finally, we delineated the merits and challenges of CCNM in the context of cancer therapy. Hoping to present the significance of CCNM as for the clinical application, and provide some clues for the novel design of CCNM and other types of nanomaterials in the future.</p>
</sec>
<sec id="s2">
<title>2 Synthesis of CCNM</title>
<p>There are currently various methods for synthesizing CCNM. According to different synthesis techniques, various shapes and sizes of particles can be obtained (<xref ref-type="bibr" rid="B88">Wu et al., 2022</xref>). All of the synthesis parameters, including reactant concentration, stirring strength of the reaction mixture, temperature, and solvent type, affect the crystal formation, particle size, and stability of CCNM (<xref ref-type="bibr" rid="B41">Li et al., 2020a</xref>; <xref ref-type="bibr" rid="B14">Devi et al., 2023</xref>). The main synthesis methods of CCNM, such as precipitation method (<xref ref-type="bibr" rid="B20">Febrida et al., 2021</xref>), mechano-chemical method (<xref ref-type="bibr" rid="B63">Preksha et al., 2021</xref>), sea shell and eggshell mediated (<xref ref-type="bibr" rid="B2">Azraian and Sutapun, 2022</xref>) and gas diffusion method (<xref ref-type="bibr" rid="B23">Gindele et al., 2021</xref>) are summarized as follows <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Comparison of advantages and disadvantages of common synthesis methods of CCNM.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Synthetic method</th>
<th align="center">Scope of application</th>
<th align="center">Superiority</th>
<th align="center">Drawback</th>
<th align="center">(Refs.)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">precipitation method</td>
<td align="center">laboratory</td>
<td align="center">low cost, simple and easy to operate</td>
<td align="center">uneven size and morphology</td>
<td align="center">
<xref ref-type="bibr" rid="B20">Febrida et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="center">mechano-chemical method</td>
<td align="center">environment, biomedical</td>
<td align="center">difficult to reunite</td>
<td align="center">easy to be contaminated and instrument complexity</td>
<td align="center">
<xref ref-type="bibr" rid="B63">Preksha et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="center">sea shell and eggshell mediated</td>
<td align="center">biomedicine</td>
<td align="center">rich source, non-toxic, green, with drug loading capacity</td>
<td align="center">impurity of nanoparticles</td>
<td align="center">
<xref ref-type="bibr" rid="B2">Azraian and Sutapun (2022)</xref>
</td>
</tr>
<tr>
<td align="center">gas diffusion method</td>
<td align="center">biomedicine</td>
<td align="center">low cost, easy to obtain</td>
<td align="center">easy to agglomerate</td>
<td align="center">
<xref ref-type="bibr" rid="B23">Gindele et al. (2021)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s2-1">
<title>2.1 Precipitation method</title>
<p>Spontaneous precipitation reaction is that the mixture of calcium and supersaturation solution of carbonate are simply blended. It is the most important and simplest method to prepare CCNM (<xref ref-type="bibr" rid="B73">Sun et al., 2020</xref>). <xref ref-type="bibr" rid="B60">Persano et al. (2022)</xref> synthesized CCNM using this method and studied in detail the effects of different synthesis parameters. They found that as the stirring speed increased, the nano size of CaCO<sub>3</sub> decreased correspondingly. Meanwhile, it was found that the higher the salt concentration, the higher the supersaturation became, and thus the smaller the nano size. <xref ref-type="bibr" rid="B93">Yang et al. (2021a)</xref> used CaCl<sub>2</sub> and NaCO<sub>3</sub> as raw materials, injected NaCO<sub>3</sub> into the CaCl<sub>2</sub> containing Ca(OH)<sub>2</sub> to prepare CCNM, and studied the use of Ca(OH)<sub>2</sub> as an additive. As a non-impurity additive, Ca(OH)<sub>2</sub> increased the pH value of the suspension. The results showed that the higher the pH value of the reaction system, the smaller the CCNM size. <xref ref-type="bibr" rid="B59">P&#xe9;rez-Villarejo et al. (2018)</xref> reported a simple and rapid method for synthesizing CCNM. The experiment used Ca(NO<sub>3</sub>)<sub>2</sub>&#xb7;4H<sub>2</sub>O and NaHCO<sub>3</sub> as raw materials and mainly observed the role of sucrose as an additive in the synthesis of CCNM. Their conclusion is that sucrose interacts with Ca<sup>2&#x2b;</sup> and water molecules through hydroxyl groups. The higher the concentration of sucrose, the more crystalline forms of synthetic vaterite, and the smaller the size of nanoparticles. Sucrose can stabilize the vaterite crystal form, making it difficult to transform into a more stable calcite crystal form, which provides a fast and simple method for the synthesis of vaterite crystal form in the future.</p>
<p>Based on the application experience, the precipitation method has been reported to involve the addition of different molecules, including synthetic polymers, surfactants and biomolecules, to synthesize CCNM of different sizes and shapes. This method can adjust the crystal morphology and particle size of CCNM by changing the concentration of reactants and adding organic matter. However, the rapid reaction speed of precipitation reaction, which is not conducive to observing and studying the reaction process. This might be its main drawback.</p>
</sec>
<sec id="s2-2">
<title>2.2 Mechano-chemical method</title>
<p>The mechano-chemical synthesis method to produce CCNM is the process involving mechanical fragmentation and chemical reactions (<xref ref-type="bibr" rid="B7">Cestari et al., 2021</xref>). Its chemical reaction occurs through the absorption of mechanical energy by reactants. This method is divided into the dry mechano-chemical and the wet mechano-chemical method (<xref ref-type="bibr" rid="B55">Mkhize et al., 2021</xref>). <xref ref-type="bibr" rid="B22">Gbadenyan et al. (2021)</xref> prepared CCNM by mechano-chemical grinding method. They started with using stainless steel balls and cans to grind the snail shell to obtain fine particles. Then, the fine particles are placed in a stainless steel wide-mouthed bottle, solvent is added, and wet grinding is performed to obtain CCNM. Compared with precipitation method, the equipment setup for the mechano-chemical method is cost-effective and enables the agglomeration-free production of nanoparticles with narrow particle size distribution (<xref ref-type="bibr" rid="B61">Piras et al., 2019</xref>). But this method also has some drawbacks, such as instrument rusting, which may hinder the synthesis process of nanoparticles and cause certain pollution.</p>
</sec>
<sec id="s2-3">
<title>2.3 Sea shell and eggshell mediated</title>
<p>It is advantageous to synthesize CCNM using natural reserves of CaCO<sub>3</sub>, such as eggshells and seashells, as it is easy to obtain, non-toxic, and biocompatible, making it an ideal candidate for biomedical applications (<xref ref-type="bibr" rid="B64">Prihanto et al., 2023</xref>). <xref ref-type="bibr" rid="B67">Rinu et al. (2020)</xref> synthesized nanoparticles using eggshells as raw materials. By collecting a large amount of eggshells and drying them at room temperature. Then gently crush the eggshell and place it in a crucible, keeping it in a muffle furnace at 900&#xb0;C for 2&#xa0;h. Finally, it is turned into fine powder to synthesize CCNM. <xref ref-type="bibr" rid="B36">Khan et al. (2019)</xref> used eggshells and agar as raw materials to calcine the synthesized products at high temperatures, ultimately synthesizing CCNM. The calcination temperature has a significant impact on the morphology, composition, and size of particles. <xref ref-type="bibr" rid="B29">Hussein et al. (2020)</xref> crushed the shells into powder and mixed them with HCl to form CaCl<sub>2</sub>. And the effect of different volumes of double-distilled water (DDW) on the morphology of CCNM derived from shells was studied. Nanoparticles prepared with different volumes of DDW have different shapes and sizes, which is due to the dilution of the solution volume by DDW, resulting in changes in the activity space of the nanoparticles.</p>
<p>Seashells and eggshells are abundant in resources, inexpensive, and easy to obtain, which can reduce environmental pollution levels and have good economic and social benefits. From this, it can be seen that CCNM obtained through shells and eggshells has enormous advantages, but the resulting nanoparticles are impure, which requires further exploration.</p>
</sec>
<sec id="s2-4">
<title>2.4 Gas diffusion method</title>
<p>The gas diffusion method has been widely used to synthesize CCNM in the biomedical field. This method involves the thermal decomposition of (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub> or NH<sub>4</sub>HCO<sub>3</sub> to generate CO<sub>2</sub> and NH<sub>3</sub> diffusion into an ethanol solution containing calcium salts to generate precipitates or the introduction of CO<sub>2</sub> gas into the calcium salt ethanol solution at atmospheric pressure to synthesize CCNM (<xref ref-type="bibr" rid="B82">Wang et al., 2020</xref>). <xref ref-type="bibr" rid="B10">Chuzeville et al. (2022)</xref> used this method to synthesize the dispersed CCNM below 150&#xa0;nm in ethanol. Ethanol is the main solvent to ultimately obtain stable and uniform spherical nanoparticles, which can inhibit the spontaneous aggregation and crystallization of CCNM. <xref ref-type="bibr" rid="B31">Ju et al. (2022)</xref> made some improvements on the basis of the original steps. In the ethanol-water binary system, stable amorphous calcium carbonate (ACC) nanospheres were synthesized by gas diffusion method. And different volumes of ammonia were added to the solution, it was observed that as ammonia was continuously added, the volume of the nanomaterials continued to decrease. <xref ref-type="bibr" rid="B90">Xu et al. (2022a)</xref> synthesized ACC by gas diffusion method, added Ca(OH)<sub>2</sub> and CO<sub>2</sub> in the methanol-water system, reacted in an autoclave and centrifuged to obtain ACC. The research results indicate that with the increase of water content in the solution system, ACC gradually changed into a metastable vaterite crystal.</p>
<p>Compared to other synthesis methods, gas-phase diffusion method has the advantage of controllable reaction speed. There is no need for other additives, and higher product quality could be acquired. Thus, it is often used as the preferred method for studying the biomimetic synthesis of CCNM minerals. But the obtained nanoparticles are still easy to agglomerate. Polyethylene glycol and other substances can be used to modify the surface of CCNM to improve the dispersion and stability in aqueous solution.</p>
</sec>
</sec>
<sec id="s3">
<title>3 Application of CCNM in cancer treatment</title>
<p>CCNM not only have great potential in imaging and biosensing but also play an important role in fields such as dental materials and bone regeneration (<xref ref-type="bibr" rid="B40">Li et al., 2021b</xref>; <xref ref-type="bibr" rid="B56">Niu et al., 2022</xref>). Due to their excellent biocompatibility and pH responsiveness, CCNM have great developing prospects in cancer treatment, especially in delivery systems, tumor diagnosis, Ca<sup>2&#x2b;</sup> overload, pH regulation, and coagulation induction (<xref ref-type="bibr" rid="B57">Novoselova et al., 2021</xref>; <xref ref-type="bibr" rid="B100">Zhao et al., 2023</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). The different roles of CCNM in cancer treatment are listed in <xref ref-type="table" rid="T2">Table 2</xref>.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Applications of CCNM in cancer treatment.</p>
</caption>
<graphic xlink:href="fbioe-11-1266888-g002.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Different roles of CCNM in cancer treatment.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Composition</th>
<th align="center">Preparation method</th>
<th align="center">Therapeutic methods</th>
<th align="center">CCNM function</th>
<th colspan="2" align="center">(Refs.)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">CUR, CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">Ca<sup>2&#x2b;</sup> overload/immunotherapy</td>
<td colspan="2" align="center">carrier, Ca<sup>2&#x2b;</sup> overload</td>
<td align="center">
<xref ref-type="bibr" rid="B102">Zheng et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="center">DOX, CCNM</td>
<td align="center">coprecipitation</td>
<td align="center">chemotherapy</td>
<td colspan="2" align="center">carrier</td>
<td align="center">
<xref ref-type="bibr" rid="B62">Popova et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="center">ICG, DOX, CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">chemotherapy/PTT</td>
<td colspan="2" align="center">carrier</td>
<td align="center">
<xref ref-type="bibr" rid="B97">Yu et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="center">hAS, PDA, PEG, CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">PTT/chemotherapy</td>
<td colspan="2" align="center">carrier</td>
<td align="center">
<xref ref-type="bibr" rid="B103">Zhong et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="center">Cu<sub>2</sub>O, HA, CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">PTT/photodynamic therapy (PDT)/chemodynamic therapy (CDT)/Ca<sup>2&#x2b;</sup> overload</td>
<td colspan="2" align="center">Ca2&#x2b; overload</td>
<td align="center">
<xref ref-type="bibr" rid="B8">Chang et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="center">CDDP, OA, CCNM</td>
<td align="center">micro emulsion</td>
<td align="center">chemotherapy</td>
<td colspan="2" align="center">carrier</td>
<td align="center">
<xref ref-type="bibr" rid="B35">Khan et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="center">Capsaicin, CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">Ca<sup>2&#x2b;</sup> overload</td>
<td colspan="2" align="center">carrier, Ca<sup>2&#x2b;</sup> overload</td>
<td align="center">
<xref ref-type="bibr" rid="B91">Xu et al. (2022b)</xref>
</td>
</tr>
<tr>
<td align="center">Ce6, Cu<sup>2&#x2b;</sup>, CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">Ca<sup>2&#x2b;</sup> overload/CDT/sonodynamic therapy (SDT)</td>
<td colspan="2" align="center">Ca<sup>2&#x2b;</sup> overload</td>
<td align="center">
<xref ref-type="bibr" rid="B99">Zhao et al. (2022a)</xref>
</td>
</tr>
<tr>
<td align="center">TCL, CpG, CCNM</td>
<td align="center">precipitation</td>
<td align="center">immunotherapy</td>
<td colspan="2" align="center">consuming excessive hydrogen ions and lactate, carrier</td>
<td align="center">
<xref ref-type="bibr" rid="B15">Ding et al. (2023)</xref>
</td>
</tr>
<tr>
<td align="center">Fe<sup>2&#x2b;</sup>, GA, Pt (IV)-SA, CCNM</td>
<td align="center">precipitation</td>
<td align="center">ferroptosis/chemotherapy</td>
<td colspan="2" align="center">carrier</td>
<td align="center">
<xref ref-type="bibr" rid="B27">Han et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="center">iridium (III), CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">Ca<sup>2&#x2b;</sup> overload/PDT</td>
<td colspan="2" align="center">carrier, Ca<sup>2&#x2b;</sup> overload</td>
<td align="center">
<xref ref-type="bibr" rid="B70">Shen et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="center">Fe<sup>2&#x2b;</sup>, CCNM, O<sub>2</sub>, COF, FA</td>
<td align="center">gas diffusion</td>
<td align="center">PDT/Ca<sup>2&#x2b;</sup> overload</td>
<td colspan="2" align="center">Ca<sup>2&#x2b;</sup> overload</td>
<td align="center">
<xref ref-type="bibr" rid="B105">Zhou et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="center">KAE, M, CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">Ca<sup>2&#x2b;</sup> overload/chemotherapy</td>
<td colspan="2" align="center">Ca<sup>2&#x2b;</sup> overload</td>
<td align="center">
<xref ref-type="bibr" rid="B46">Li et al. (2021c)</xref>
</td>
</tr>
<tr>
<td align="center">CDDP, CUR, CCNM, PEG</td>
<td align="center">gas diffusion</td>
<td align="center">Ca<sup>2&#x2b;</sup> overload/chemotherapy</td>
<td colspan="2" align="center">Ca<sup>2&#x2b;</sup> overload</td>
<td align="center">
<xref ref-type="bibr" rid="B101">Zheng et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="center">CCNM</td>
<td align="center">gas diffusion/double decomposition reaction</td>
<td align="center">alkalization of TME</td>
<td colspan="2" align="center">modulate tumor pH</td>
<td align="center">
<xref ref-type="bibr" rid="B72">Som et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="center">CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">alkalization of TME</td>
<td colspan="2" align="center">modulate tumor pH</td>
<td align="center">
<xref ref-type="bibr" rid="B38">Lam et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="center">DOX, CCNM</td>
<td align="center">emulsion</td>
<td align="center">starving tumor therapy/chemotherapy</td>
<td colspan="2" align="center">induce blood coagulation, carrier</td>
<td align="center">
<xref ref-type="bibr" rid="B42">Li et al. (2020b)</xref>
</td>
</tr>
<tr>
<td align="center">NaGdF<sub>4</sub>, CCNM</td>
<td align="center">gas diffusion</td>
<td align="center">___</td>
<td colspan="2" align="center">carrier, produce CO<sub>2</sub> aid in imaging</td>
<td align="center">
<xref ref-type="bibr" rid="B96">Yi et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="center">DOX, CCNM</td>
<td align="center">
<italic>in-situ</italic> polymerization</td>
<td align="center">chemotherapy</td>
<td colspan="2" align="center">carrier, produce CO<sub>2</sub> aid in imaging</td>
<td align="center">
<xref ref-type="bibr" rid="B28">Huang et al. (2020)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s3-1">
<title>3.1 CCNM as carriers for delivering anticancer drugs</title>
<p>An ideal anticancer drug delivery system is to deliver the drug directly to the target site, with minimal impact on normal cells, thereby improving treatment efficiency and producing minimal toxic side effects. Numerous tumor targeted drug delivery systems have been constructed through nanotechnology, which not only improves drug stability but also limits drug toxicity (<xref ref-type="bibr" rid="B19">Elbaz et al., 2020</xref>). CCNM have received great attention among different inorganic nanocarriers. Their natural characteristics such as biocompatibility, pH responsiveness and high encapsulation efficiency make them an ideal carrier for transporting various bioactive substances, especially anticancer drugs and genes (<xref ref-type="bibr" rid="B21">Fu et al., 2019</xref>). Therefore, when CCNM are coupled with drugs and genes, they improve the efficiency of disease treatment.</p>
<p>At present, there are two main ways for CCNM to deliver drugs for tumor treatment. One method involves directly binding anti-tumor drugs onto the surface of CCNM, while the other method involves co-doping drugs with CCNM and allowing the complex to enter tumor cells (<xref ref-type="bibr" rid="B75">Teixeira et al., 2022</xref>). <xref ref-type="bibr" rid="B102">Zheng et al. (2022)</xref> used the one-pot gas diffusion method to co-dope curcumin (CUR) with CCNM, and the obtained CCNM can decompose at low pH to release CUR. Among them, CUR causes cell apoptosis by affecting Ca<sup>2&#x2b;</sup> homeostasis. By using CCNM as a carrier to transport CUR, the programmed release of CUR at the tumor site was achieved, improving the transport efficiency and anticancer activity of CUR.</p>
<p>
<xref ref-type="bibr" rid="B62">Popova et al. (2021)</xref> loaded DOX onto the surface of CCNM, with the aim of studying the coupling efficiency of CCNM with drugs and the effectiveness of carrying DOX in inhibiting cancer cell proliferation <italic>in vitro</italic>. In an <italic>in vitro</italic> model, the composite material of CCNM and DOX was shown to effectively inhibit the growth of cancer cells. The characteristics of CCNM also help prevent unnecessary accumulation of DOX in major organs such as the liver, heart, and kidneys.</p>
<p>On this basis, drug delivery systems can be designed to combine multiple treatment methods into an intelligent carrier, providing a solution for their potential applications in cancer diagnosis and treatment. As shown in <xref ref-type="fig" rid="F3">Figure 3A</xref>, <xref ref-type="bibr" rid="B97">Yu et al. (2023)</xref> co-doped CCNM with indocyanine green (IGG) before loading DOX on the surface, then encapsulated them with poly (lactic-co-glycolic acid)-ss-chondroitin sulfate A (PSC). This study combines photothermal therapy (PTT) with chemotherapy to treat tumors. PTT can use photosensitizers to generate heat energy and ultimately eliminate tumor cells. IGG is an effective photosensitizer, but free IGG cannot selectively reach the tumor site. Utilizing CCNM delivered IGG to reach the tumor site for PTT. This method not only enables IGG to accurately reach tumor cells but also significantly increases the metabolic time of IGG and improves treatment efficiency. As shown in <xref ref-type="fig" rid="F3">Figure 3B</xref>, compared with other control groups, the experimental group significantly inhibited the tumor volume of mice. It was observed in the mouse thermal image in <xref ref-type="fig" rid="F3">Figure 3C</xref> that this nanomaterial helps IGG to better exert its therapeutic effect. Observing from the picture, the tumor temperature in the 5% glucose group was slightly increased after 5&#xa0;min of laser irradiation. The free DOX &#x2b; ICG group exhibited the tumor temperature with an increase to 45.4&#xb0;C. Notably, PSC/ICG@ and PSC/ICG@&#x2b;DOX groups showed an increased temperature of 60.5&#xb0;C after 5&#xa0;min irradiation, which could effectively generate hyperthermia for PTT of malignant tumors. From this, it can be seen that CCNM have enormous advantages in delivery systems. At the same time, we can further study its synthesis method and functionalization to generate CCNM with different morphologies, thereby achieving higher loading efficiency and achieving better therapeutic effects.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>CCNM are loaded with active substances to treat tumors: <bold>(A)</bold> Schematic diagram of PSC/ICG@&#x2b;DOX nanoparticle synthesis and mediated apoptosis; <bold>(B)</bold> Tumor growth curves of mice after the treatment; <bold>(C)</bold> Laser imaging of mice (<xref ref-type="bibr" rid="B97">Yu et al., 2023</xref>). Copyright 2023 Dove Medical Press Limited.</p>
</caption>
<graphic xlink:href="fbioe-11-1266888-g003.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Ca<sup>2&#x2b;</sup> overload</title>
<p>As a pivotal second messenger in cellular signaling, Ca<sup>2&#x2b;</sup> orchestrates the precise regulation of diverse physiological processes through targeted activation of specific proteins (<xref ref-type="bibr" rid="B45">Liu et al., 2020c</xref>). Under normal circumstances, the concentration of cytoplasmic free Ca<sup>2&#x2b;</sup> is maintained at a significantly low level of approximately 100&#xa0;nmol/L. There is a 10<sup>4</sup> &#x223c; 10<sup>5</sup> -fold gradient of Ca<sup>2&#x2b;</sup> concentration between outside and inside of cells (<xref ref-type="bibr" rid="B3">Bai et al., 2022</xref>). Without the stimulation of abnormal conditions, the intracellular Ca<sup>2&#x2b;</sup> concentration is lower than the level of extracellular fluid, which plays an active role in regulating cells (<xref ref-type="bibr" rid="B52">Ma et al., 2020</xref>; <xref ref-type="bibr" rid="B18">Eisner et al., 2023</xref>). But if the concentration of Ca<sup>2&#x2b;</sup> exceeds the normal range, it will cause damage to the cells. Therefore, regulating Ca<sup>2&#x2b;</sup> concentration has broad research prospects in tumor treatment. In recent years, Ca<sup>2&#x2b;</sup> overload treatment has garnered significant attention in the field of tumor treatment, with a close association between Ca<sup>2&#x2b;</sup> and mitochondria (<xref ref-type="bibr" rid="B106">Zhu et al., 2019</xref>). When intracellular Ca<sup>2&#x2b;</sup> overload occurs, the mitochondrial Ca<sup>2&#x2b;</sup> uniporter (MCU) sequesters intracellular Ca<sup>2&#x2b;</sup>. Upon reaching a certain threshold, this uptake of Ca<sup>2&#x2b;</sup> by mitochondria triggers the opening of the mitochondrial permeability transition pore (PTP) (<xref ref-type="bibr" rid="B24">Glitsch, 2019</xref>; <xref ref-type="bibr" rid="B13">Delierneux et al., 2020</xref>). When PTP is opened, many large molecules non-selectively diffuse from cytoplasm to mitochondria, leading to the destruction and dysfunction of mitochondrial membrane potential. Mitochondrial Ca<sup>2&#x2b;</sup> overload can lead to the release of cytochrome C and the activation of aspartate proteolytic enzymes, thereby damaging the production of reactive oxygen species related to the respiratory chain and affecting mitochondrial function, ultimately leading to cell apoptosis (<xref ref-type="bibr" rid="B6">Calvo-Rodriguez and Bacskai, 2021</xref>). After mitochondrial damage, biological transmission electron microscopy (Bio-TEM) is commonly employed to examine the morphology and abundance of mitochondria. At the same time, Flou-4 AM calcium probe is commonly used to detect intracellular Ca<sup>2&#x2b;</sup> (<xref ref-type="bibr" rid="B101">Zheng et al., 2021</xref>), while the Rhod-2 AM probe is used for detecting Ca<sup>2&#x2b;</sup> in mitochondria (<xref ref-type="bibr" rid="B85">Wang et al., 2023b</xref>).</p>
<p>Inadequate Ca<sup>2&#x2b;</sup> at the tumor site, intracellular Ca<sup>2&#x2b;</sup> channels can also effectively regulate the concentration of Ca<sup>2&#x2b;</sup>, so it is difficult to achieve effective Ca<sup>2&#x2b;</sup> overload. Providing Ca<sup>2&#x2b;</sup> solely through calcium materials cannot achieve satisfactory results (<xref ref-type="bibr" rid="B37">Kong et al., 2021</xref>). Therefore, more and more collaborative treatment methods have been developed and have attracted widespread attention. For example, combining calcium nanomaterials with treatment methods such as chemotherapy can not only provide Ca<sup>2&#x2b;</sup>, but also disrupt calcium homeostasis, thereby achieving more effective Ca<sup>2&#x2b;</sup> overload. As shown in <xref ref-type="fig" rid="F4">Figure 4A</xref>, <xref ref-type="bibr" rid="B46">Li et al. (2021c)</xref> designed the M@CaCO<sub>3</sub>@KAE nano platform, thus realizing the cooperative and targeted therapy of tumors. Among them, Kaempferol-3-O-Rutinoside (KAE) can effectively disrupt the regulation of Ca<sup>2&#x2b;</sup> homeostasis and promote Ca<sup>2&#x2b;</sup> influx, while CCNM can provide Ca<sup>2&#x2b;</sup>, ultimately achieving Ca<sup>2&#x2b;</sup> overload and mitochondrial structure and function are disrupted, causing cytoskeletal collapse and oxidative stress, leading to cancer cell apoptosis. In <xref ref-type="fig" rid="F4">Figures 4B, C</xref>, it was observed that the tumor volume of mice was effectively suppressed, indicating that this nanomaterial can to some extent inhibit tumor growth, which is of great significance for clinical applications. This experiment cleverly combines KAE with CaCO<sub>3</sub>, greatly increasing the concentration of intracellular Ca<sup>2&#x2b;</sup>, thereby achieving more efficient treatment of tumors with Ca<sup>2&#x2b;</sup> overload, providing a unique and novel approach for our future Ca<sup>2&#x2b;</sup> overload experiments. In addition, as shown in <xref ref-type="fig" rid="F4">Figure 4D</xref>, <xref ref-type="bibr" rid="B101">Zheng et al. (2021)</xref> successfully prepared CCNM codoped with cisplatin (CDDP) and CUR. They destroyed the structure and function of mitochondria through CDDP, and destroyed the endoplasmic reticulum through CUR, so that a large amount of Ca<sup>2&#x2b;</sup> entered the cytoplasm, and CaCO<sub>3</sub> provided a large amount of Ca<sup>2&#x2b;</sup>, thus achieving efficient Ca<sup>2&#x2b;</sup> overload. Due to the fluorescence characteristics of CUR, it was observed in <xref ref-type="fig" rid="F4">Figure 4E</xref> that the fluorescence signal of the mouse tumor site became stronger within the first 12&#xa0;h, further indicating that the CCNM nano platform has a certain degree of targeting and can accumulate within the tumor. The Ca<sup>2&#x2b;</sup> nanomodulator designed in this experiment achieves Ca<sup>2&#x2b;</sup> overload in multiple directions, targeting cancer through mitochondria, and has great prospects in clinical practice. Ca<sup>2&#x2b;</sup> overload is one of the most effective methods to induce cancer cell apoptosis. Upregulation of Ca<sup>2&#x2b;</sup> concentration in mitochondria can lead to a series of mitochondrial diseases, including decreased mitochondrial membrane potential, decreased ATP levels, altered mitochondrial morphology, and mitochondrial respiratory disorders (<xref ref-type="bibr" rid="B25">Guan et al., 2020</xref>). The use of ion interference to treat tumors is extremely ingenious in concept, providing a new perspective for tumor treatment. Ca<sup>2&#x2b;</sup> overload has gradually become a research hotspot, but simply killing tumor cells through Ca<sup>2&#x2b;</sup> overload is far from enough. We can use other methods for combined therapy to greatly improve the treatment efficiency of tumors.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>
<bold>(A)</bold> Schematic illustration of M@CaCO<sub>3</sub>@KAE NP-mediated apoptosis; <bold>(B)</bold> The photos of tumors; <bold>(C)</bold> The inhibition rate of tumor weights I: Control; II: CaCO<sub>3</sub> NPs; III: KAE; &#x2163;: CaCO<sub>3</sub>@KAE NPs; &#x2164;: M@CaCO<sub>3</sub>@KAE NPs (<xref ref-type="bibr" rid="B46">Li et al., 2021c</xref>) Copyright 2021 Elsevier; <bold>(D)</bold> Schematic diagram of cell apoptosis mediated by <sup>PEG</sup>CaNM<sub>CUR&#x2b;CDDP</sub> nanoparticles; <bold>(E)</bold> PA imaging of mice (<xref ref-type="bibr" rid="B101">Zheng et al., 2021</xref>). Copyright 2021 WILEY-VCH Verlag GmbH &#x26; Co. KGaA, Weinheim.</p>
</caption>
<graphic xlink:href="fbioe-11-1266888-g004.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 CCNM modulate tumor pH</title>
<p>Due to metabolic disorders in tumors, the extracellular pH of solid tumors is lower than that of normal tissues. The acidic extracellular environment of tumors enhances their invasiveness and metastasis, but there are few methods to selectively regulate the extracellular pH environment of tumors. It is impractical and non-selective to flush biological system instantaneously with alkaline liquid or proton pump inhibitor (<xref ref-type="bibr" rid="B87">Worsley et al., 2022</xref>). Among various methods for regulating the acidic environment of tumor cells, CCNM are particularly effective because they have efficient buffering ability and can directly regulate pH values.</p>
<p>On this basis, <xref ref-type="bibr" rid="B72">Som et al. (2016)</xref> prepare monodisperse CCNM with a size range of 20&#x2013;300&#xa0;nm, intentionally adjusting the pH value of the tumor microenvironment (TME). It utilized a mouse cancer model and repeated daily injections of CCNM, which significantly inhibited tumor growth. And in detecting dynamic pH values in tumor mice, it was observed that the pH value increased almost linearly during the first 30&#xa0;min. This experiment demonstrates that CCNM can increase the pH value of tumors and inhibit tumor growth over time in tumors. It demonstrated for the first time the ability of using CCNM to regulate the pH value in solid tumors and observed that the effective alkalization of tumor acidic pH depends on the size of the nanoparticles. It should be noted that in order to achieve sustained tumor suppression effects in future experiments, it is necessary to optimize the dosage and use CCNM in combination with other therapies to improve the targeting of CCNM to tumors. <xref ref-type="bibr" rid="B38">Lam et al. (2021)</xref> co incubated cancer cells and fibroblasts and then treated them with CCNM. The results showed that nanoparticles selectively inhibited the growth of tumor cells, and reduced the cell migration of these cells, but had no effect on fibroblasts. This indicates that CCNM can limit the invasiveness of tumor cells without affecting the growth and behavior of surrounding stromal cells. The advantage of this experiment compared to other experiments is that it uses microfluidic devices to simulate the flow parameters in the body to determine the impact of pH changes on tumor survival and migration. Research has shown that CCNM can indeed alter the acidic microenvironment of tumors, but relying solely on CCNM to alter the acidic environment is still not enough.</p>
</sec>
<sec id="s3-4">
<title>3.4 CCNM induce coagulation</title>
<p>To remedy the intrinsic deficits in energy production, cancer cells typically increase their uptake of extracellular glucose. Thus, the glucose deprivation is an effective way to cause the rapid and massive death of cancer cells, which is the essence of starving cancer cells. Based on the concept of cancer hunger treatment, as shown in <xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="bibr" rid="B42">Li et al. (2020b)</xref> explored the effect of CCNM on coagulation. In <xref ref-type="fig" rid="F5">Figure 5B</xref>, it was observed that in a mouse breast tumor model, CCNM were injected locally and physiological saline was used as the control. Through naked eye, HE, and Masson trichrome staining, it was found that CCNM, under the influence of acid stimulation, can cause coagulation reactions and thrombosis in tumor blood vessels, resulting in abnormal blood circulation and glucose supply. Therefore, CCNM have great prospects in the field of cancer treatment. Among them, Ca<sup>2&#x2b;</sup> activates prothrombin to thrombin, thereby causing blood to coagulate. And as the pH decreases, CCNM release more Ca<sup>2&#x2b;</sup>, causing faster blood coagulation. The characteristic of CCNM that are pH sensitive and induce blood coagulation makes them a promising material for cancer hunger treatment. Although this study demonstrates that CCNM can induce coagulation in tumor blood vessels, it still cannot cover all tumor blood vessels, which requires further exploration.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>
<bold>(A)</bold> CCNM induces blood coagulation; <bold>(B)</bold> Observation of blood coagulation <italic>in vivo</italic> (<xref ref-type="bibr" rid="B42">Li et al., 2020b</xref>) Copyright 2020 Royal Society of Chemistry; <bold>(C)</bold> Schematic diagram of synthesis of nanomaterials; <bold>(D)</bold> MRI of mice (<xref ref-type="bibr" rid="B96">Yi et al., 2019</xref>). Copyright 2019 WILEY-VCH Verlag GmbH &#x26; Co. KGaA, Weinheim.</p>
</caption>
<graphic xlink:href="fbioe-11-1266888-g005.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Application of CCNM in tumor diagnosis</title>
<p>In recent years, the development of high-performance contrast agents in magnetic resonance imaging (MRI) has received great attention. As shown in <xref ref-type="fig" rid="F5">Figure 5C</xref>, <xref ref-type="bibr" rid="B96">Yi et al. (2019)</xref> designed and synthesized a new type of nanoparticle contrast agent, including self-assembled NaGdF<sub>4</sub> and CaCO<sub>3</sub> nanoconjugates, providing an integrated MRI nano platform with high tumor selectivity and good biocompatibility. In this design, the spatial confinement of the Gd<sup>3&#x2b;</sup> leads to an &#x201c;OFF&#x201d; MRI signal due to insufficient interaction between the protons and the crystal lattices. However, when immersed in the mildly acidic TME the embedded CCNM generate CO<sub>2</sub> bubbles and subsequently disconnect the nanoconjugates, thus resulting in an &#x201c;ON&#x201d; MRI signal. Due to the excellent performance of nanomaterials <italic>in vitro</italic>, <xref ref-type="bibr" rid="B96">Yi et al. (2019)</xref> investigated their comparative ability <italic>in vivo</italic> (<xref ref-type="fig" rid="F5">Figure 5D</xref>). T1-weighted MR images were acquired <italic>in vivo</italic> before and after intravenous injection of nanoconjugates. The tumor site is relatively dark before injection of nanoconjugates, and it starts to light up about 30&#xa0;min after injection. The contrast enhancement at the tumor site reached a tumor-to-background ratio of approximately 48 at 195&#xa0;min postinjection. Compared with commonly used magnetic contrast agents, the <italic>in vivo</italic> performance of NaGdF<sub>4</sub>-CaCO<sub>3</sub> shows a 60-fold enhancement in tumor visualization. It is suitable for deep tissue imaging, with higher sensitivity and selectivity, which is of great significance for constructing intelligent magnetic resonance imaging.</p>
<p>In addition, CCNM can generate CO<sub>2</sub> bubbles under acidic conditions, which can then enhance ultrasound imaging signals. <xref ref-type="bibr" rid="B28">Huang et al. (2020)</xref> developed a diagnostic nanoparticle system for ultrasound and fluorescence dual-mode imaging. The nanoparticle loaded with DOX showed the ability to simultaneously treat cancer. Therefore, loading DOX onto CCNM yields CaCO<sub>3</sub>-DOX nanoparticles. Under acidic conditions, CCNM generate CO<sub>2</sub> to enhance ultrasound imaging and increase the release of DOX, thereby improving the quality of ultrasound imaging. Also, ICG was encapsulated into CCNM, to further detect the tumor with fluorescence. Overall, this study integrates imaging and therapeutic functions to provide a promising and attractive strategy for cancer treatment. Through research, it has been found that CCNM have certain help and advantages in the diagnosis of tumors. But there are still shortcomings such as instability and weak targeting of CCNM. It is necessary to improve their targeting and stability in order to maximize the diagnostic role of CCNM in tumors. Meanwhile, <xref ref-type="bibr" rid="B80">Vidallon et al. (2020)</xref> synthesized hybrid CCNM with biocompatibility and pH sensitivity through rapid precipitation method. Among them, CCNM can undergo decomposition under acidic conditions to generate high echo CO<sub>2</sub> bubbles, increasing the contrast intensity of ultrasound and demonstrating its potential as an ultrasound contrast agent.</p>
<p>Compared to traditional ultrasound contrast agents, CCNM not only achieve long-term stability of ultrasound imaging but also can quickly clear in the body without causing harm to the human body (<xref ref-type="bibr" rid="B51">Ma et al., 2022</xref>). At the same time, appropriate surface modification can also endow particles with specific targeting. The mesoporous structure generated by CCNM polymerization can encapsulate therapeutic drugs such as chemotherapy and sound sensitizers with good drug loading and release performance (<xref ref-type="bibr" rid="B65">Qiao et al., 2020</xref>). Therefore, combining the diagnosis and treatment functions of CCNM play an important role in improving the diagnosis and treatment technology of tumors.</p>
</sec>
</sec>
<sec id="s4">
<title>4 Advantages of CCNM</title>
<p>Now the enormous potential of CCNM have gradually been discovered in the field of biomedicine. CCNM not only have unique characteristics such as good biocompatibility and low cost but also have a large specific surface area and are easy to functionalize on the surface (<xref ref-type="bibr" rid="B66">Ren et al., 2023</xref>; <xref ref-type="bibr" rid="B77">Torgbo et al., 2023</xref>). Therefore, CCNM play a huge advantage in delivery systems. In addition, the acid responsive properties of CCNM have great application value in passive and active targeting of cancer cells and have received widespread attention in cancer treatment, bringing new hope to cancer treatment (<xref ref-type="bibr" rid="B83">Wang et al., 2022</xref>).</p>
<sec id="s4-1">
<title>4.1 Acid sensitivity</title>
<p>The acid sensitivity of CCNM make them particularly attractive in cancer treatment because micro acidity is a characteristic of TME (<xref ref-type="bibr" rid="B49">Lu et al., 2021</xref>). CaCO<sub>3</sub> can be dissolved into non-toxic products (Ca<sup>2&#x2b;</sup>, CO<sub>3</sub>
<sup>2&#x2212;</sup>) in some acidic environments, which has been used as a drug delivery system (<xref ref-type="bibr" rid="B98">Zhao et al., 2022b</xref>; <xref ref-type="bibr" rid="B9">Chiang et al., 2022</xref>). <xref ref-type="bibr" rid="B90">Xu et al. (2022a)</xref> loaded anticancer drugs 5-fluorouracil (5-FU) and CUR with CCNM as carriers and placed the drug-loaded CCNM in phosphate buffers (pH 5.8, 6.6, 7.4) to observe the pH-dependent release of drugs. It was found that the release of 5-FU increased with the decrease of pH value, and the results showed that CCNM had good pH control drug release performance. Therefore, CCNM have great potential in acid responsive drug delivery.</p>
</sec>
<sec id="s4-2">
<title>4.2 Biocompatibility</title>
<p>The biosafety of nanoparticles is crucial in biomedical applications. The reduction in particle size and larger surface area makes them better absorbed by body fluids and tissues, thereby increasing their toxicity (<xref ref-type="bibr" rid="B17">Dong et al., 2022</xref>). Unlike other nanoparticles, CCNM have natural biocompatibility because Ca<sup>2&#x2b;</sup> and CO<sub>3</sub>
<sup>2&#x2212;</sup> ions are already widely present in the human body and have not shown cytotoxic effects in normal cell and <italic>in vivo</italic> studies (<xref ref-type="bibr" rid="B95">Yang et al., 2021b</xref>). <xref ref-type="bibr" rid="B42">Li et al. (2020b)</xref> observed through the use of rabbit red blood cells that CCNM did not cause any cell aggregation or dissolution, indicating that it has good blood compatibility.</p>
</sec>
<sec id="s4-3">
<title>4.3 High load capacity</title>
<p>The relatively large specific surface area of CCNM gives them high loading capacity. At the same time, the high porosity and well-developed internal structure of CCNM allow for the accommodation of molecules with different properties (<xref ref-type="bibr" rid="B1">Atchuda et al., 2022</xref>). These particles can effectively capture various bioactive substances, including low molecular weight compounds and large molecules. These bioactive substances are loaded onto CaCO<sub>3</sub> through physical adsorption into pores or co precipitation during particle formation, which is very important in delivery systems (<xref ref-type="bibr" rid="B33">Kanwal et al., 2022</xref>).</p>
</sec>
<sec id="s4-4">
<title>4.4 Low cost and easy synthesis</title>
<p>Due to high costs and potential material safety issues, new nano formulations used for targeted drug delivery are significantly hindered when transitioning from the laboratory to the clinical setting. CaCO<sub>3</sub> is the most abundant mineral in nature, its production cost is significantly lower than that of other nanoparticles, making it a cheap inorganic material (<xref ref-type="bibr" rid="B32">Kaiping et al., 2023</xref>). Therefore, CCNM are an extremely important material in the biomedical field. At the same time, compared with other nanomaterials, the preparation of CCNM only requires the use of basic salts (calcium salts and carbonates) and often does not require the use of organic solvents. This simple manufacturing process reduces the cost of CCNM (<xref ref-type="bibr" rid="B78">Trushina et al., 2022</xref>).</p>
</sec>
<sec id="s4-5">
<title>4.5 Easy functionalization</title>
<p>Easy functionalization is also one of the huge advantages of CCNM. Many studies have functionalized it through dry, wet, and <italic>in-situ</italic> modifications to enhance stability and targeting (<xref ref-type="bibr" rid="B26">Han et al., 2019</xref>). Due to its small particle size, high specific surface area, and high specific surface energy, CCNM are prone to particle aggregation and agglomeration during preparation and post-treatment, resulting in the formation of secondary particles, increasing particle size and losing the functionality of ultrafine particles during final use, thereby affecting practical application results (<xref ref-type="bibr" rid="B39">Lee et al., 2019</xref>; <xref ref-type="bibr" rid="B30">Ippolito et al., 2020</xref>). The key to solving this problem lies in the surface modification of CCNM, reducing the adhesion between particles, and improving its dispersibility and dispersion stability in the matrix (<xref ref-type="bibr" rid="B43">Li et al., 2019</xref>; <xref ref-type="bibr" rid="B69">Shen et al., 2019</xref>). Meanwhile, CCNM still cannot achieve precisely targeted therapy solely relying on passive targeting and acid responsiveness. Therefore, it is possible to endow the delivery system with targeting ability by coupling CCNM to targeted molecules. After the functionalization of CCNM, its <italic>in vivo</italic> stability in the blood will be higher, avoiding macrophage capture and possessing certain targeting characteristics, allowing the carrier to accumulate at specific sites (<xref ref-type="bibr" rid="B12">Dang et al., 2019</xref>). <xref ref-type="bibr" rid="B47">Li. et al. (2021d)</xref> developed a multifunctional CCNM for the targeted treatment of breast cancer and inhibition of metastasis. The CCNM were functionalized with folic acid molecules (FA) and coated with the T-cell membrane. Within the acidic TME, the CCNM undergo decomposition, leading to the release of Ca<sup>2&#x2b;</sup> ions and FA. The liberated FA molecules selectively bind to cancer cells via folate receptors and effectively suppress cancer cell migration, invasion, and proliferation. Notably, the incorporation of T cell membranes imparts tumor-targeting capabilities to the material while also preventing immune clearance within the body. This gives CCNM a prominent advantage in drug delivery systems for cancer treatment.</p>
</sec>
</sec>
<sec id="s5">
<title>5 The challenges and recommendations for future studies of CCNM</title>
<p>CCNM have been developed, and their biocompatibility, pH responsiveness, and simple preparation have good prospects in the field of tumor treatment. However, the challenges faced in treatment cannot be ignored.</p>
<sec id="s5-1">
<title>5.1 Therapeutic effect of CCNM</title>
<p>In normal individuals, there is also a certain amount of Ca<sup>2&#x2b;</sup>, so it is difficult to achieve effective therapeutic effects. Moreover, the Ca<sup>2&#x2b;</sup> channel/pump on the cell membrane has a strong regulatory function, which makes the cell Ca<sup>2&#x2b;</sup> overload quickly return to the normal level, resulting in poor anti-cancer effects (<xref ref-type="bibr" rid="B54">Marchi et al., 2020</xref>; <xref ref-type="bibr" rid="B76">Tinawi, 2021</xref>). Therefore, combination therapy can further increase the Ca<sup>2&#x2b;</sup> content to achieve effective therapeutic concentration. In recent years, drug delivery systems constructed using CCNM biomaterials have been widely studied, but the concentration of drugs delivered is limited and cannot achieve clinically effective concentrations, which cannot achieve the desired clinical effects. Some studies have shown that various molecular adjuvants, such as biopolymers or synthetic polymers, can be added to the CCNM to load more drugs and make the drug release more slowly (<xref ref-type="bibr" rid="B104">Zhou et al., 2023</xref>).</p>
</sec>
<sec id="s5-2">
<title>5.2 Biosafety of CCNM</title>
<p>Ca<sup>2&#x2b;</sup> is an element contained in the human body, which has good biocompatibility and biodegradability (<xref ref-type="bibr" rid="B86">Wang et al., 2021</xref>). However, when the Ca<sup>2&#x2b;</sup> content exceeds the limit, the effect of the Ca<sup>2&#x2b;</sup> steady-state regulation system is not very clear. Meanwhile, the inevitable leakage of Ca<sup>2&#x2b;</sup> in body fluids is a long-term issue for nanomedicine delivery systems (<xref ref-type="bibr" rid="B4">Bai et al., 2021</xref>). Excessive Ca<sup>2&#x2b;</sup> can trigger coagulation reactions, leading to the formation of blood clots and posing a threat to organisms (<xref ref-type="bibr" rid="B86">Wang et al., 2021</xref>). Moreover, a substantial number of studies solely assess the short-term toxicity of CCNM in mice by delineating organ damage subsequent to CCNM injection, which still poses challenges for accurately evaluating the biosafety of CCNM. So it is imperative to acknowledge the long-term potential risks associated with CCNM. Therefore, in order to facilitate the clinical translation of CCNM, it is imperative to conduct a comprehensive evaluation of the long-term effects of CCNM across various animal models, ranging from rodents to mammals.</p>
</sec>
<sec id="s5-3">
<title>5.3 Clinical research on CCNM</title>
<p>CCNM have been widely studied in the field of tumor diagnosis and treatment, but there are still some challenges before clinical transformation (<xref ref-type="bibr" rid="B16">Dong et al., 2020</xref>). The present preparation processes of CCNM are instable, which easily leads to large particles (<xref ref-type="bibr" rid="B79">Vavaev et al., 2022</xref>). Hence, it is imperative to devise precise techniques enabling control over size, composition, and surface modification in order to facilitate large-scale production of CCNM. In addition, the prediction of drug release kinetics for CCNM remain challenging. Despite extensive research on the pH sensitivity of CCNM, their release behavior under normal physiological conditions has not been comprehensively evaluated.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s6">
<title>6 Conclusion</title>
<p>We have summarized the different roles of CCNM in treating cancer based on the synthesis methods and advantages of CCNM. Among all of the producing methods of CCNM, gas diffusion method is mostly accepted in the medical research field. How to create simpler, more effective methods to produce CCNM with wanted size, crystal forms, and morphologies has been still the research focus as for the drug delivery system in treating cancer; plus, large-scale and controllable industrial production methods to further reduce the cost of CCNM and obtain carriers with higher targeting and drug loading are needed to further explore in the future. It is the characteristics of high loading efficiency and acid responsiveness to TME that making us give more attention to CCNM than other nanomaterial. Actually, Ca<sup>2&#x2b;</sup> itself is the universal ion in the cell, functions in nearly all aspects of the living activity, thus, Ca<sup>2&#x2b;</sup> overload in certain cells as cancer cells would do no harm to other normal cells if the perfect precision are achieved. On the other hand, CCNM are the drug delivering carrier per se, which can carry whether the chemotherapy agents or novel targeting drugs, even gene editing tools; to some extent, making precise targeting treatment more easier to realize. The most interesting thing is that the Warburg effects happens in cancer metabolism, which acts as the lure for CCNM because of the acid respond property of CCNM, that is, CCNM are not simply as the carrier, it is the metabolic interference in the cancer cells. Based on all these points, CCNM might be the ideal material in fighting the cancers.</p>
<p>Frankly, their low stability in aqueous solutions and insufficient targeting still require researchers&#x2019; attention. Moreover, the researchers still need to provide animal models for extensive research to evaluate the long-term effects of CCNM on the living body before clinical conversion.</p>
</sec>
</body>
<back>
<sec id="s7">
<title>Author contributions</title>
<p>TtL: Conceptualization, Data curation, Investigation, Methodology, Project administration, Writing&#x2013;original draft, Writing&#x2013;review and editing. ZF: Conceptualization, Investigation, Methodology, Software, Supervision, Writing&#x2013;original draft, Writing&#x2013;review and editing. XZ: Investigation, Methodology, Project administration, Software, Writing&#x2013;review and editing. TfL: Formal Analysis, Methodology, Software, Writing&#x2013;review and editing. TY: Formal Analysis, Supervision, Writing&#x2013;review and editing. LY: Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing&#x2013;review and editing.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by National Natural Science Foundation of China (No. 82160299); Inner Mongolia Natural Science Foundation (No. 2023LHMS08022).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atchudan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Perumal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Synthesis and characterization of monodispersed spherical calcium oxide and calcium carbonate nanoparticles via simple pyrolysis</article-title>. <source>Nanomaterials-Basel</source> <volume>12</volume> (<issue>14</issue>), <fpage>2424</fpage>. <pub-id pub-id-type="doi">10.3390/nano12142424</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azraian</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Sutapun</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Biogenic calcium carbonate derived from waste shells for advanced material applications: A review</article-title>. <source>Front. Mater</source> <volume>9</volume>. <pub-id pub-id-type="doi">10.3389/fmats.2022.1024977</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Connecting calcium-based nanomaterials and cancer: from diagnosis to therapy</article-title>. <source>Nano-Micro Lett.</source> <volume>14</volume>, <fpage>145</fpage>. <pub-id pub-id-type="doi">10.1007/s40820-022-00894-6</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Gain an advantage from both sides: smart size-shrinkable drug delivery nanosystems for high accumulation and deep penetration</article-title>. <source>Nano Today</source> <volume>36</volume>, <fpage>101038</fpage>. <pub-id pub-id-type="doi">10.1016/j.nantod.2020.101038</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behranvand</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nasri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zolfaghari Emameh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Khani</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hosseini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garssen</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Chemotherapy: A double-edged sword in cancer treatment</article-title>. <source>Cancer Immunol. Immun.</source> <volume>71</volume> (<issue>3</issue>), <fpage>507</fpage>&#x2013;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1007/s00262-021-03013-3</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvo-Rodriguez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bacskai</surname>
<given-names>B. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mitochondria and calcium in alzheimer&#x2019;s disease: from cell signaling to neuronal cell death</article-title>. <source>Trends Neurosci.</source> <volume>44</volume>, <fpage>136</fpage>&#x2013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2020.10.004</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cestari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Agostinacchio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Galotta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chemello</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Motta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>M. Sglavo</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Nano-hydroxyapatite derived from biogenic and bioinspired calcium carbonates: synthesis and <italic>in vitro</italic> bioactivity</article-title>. <source>Nanomater. Basel</source> <volume>11</volume> (<issue>2</issue>), <fpage>264</fpage>. <pub-id pub-id-type="doi">10.3390/nano11020264</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Colorectal tumor microenvironment-activated bio-decomposable and metabolizable Cu<sub>2</sub>O@CaCO<sub>3</sub> nanocomposites for synergistic oncotherapy</article-title>. <source>Adv. Mater</source> <volume>32</volume>, <fpage>2004647</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202004647</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>C. K.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Enhancing doxorubicin delivery in solid tumor by superhydrophobic amorphous calcium carbonate-doxorubicin silica nanoparticles with focused ultrasound</article-title>. <source>Mol. Pharm.</source> <volume>19</volume> (<issue>11</issue>), <fpage>3894</fpage>&#x2013;<lpage>3905</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.2c00384</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuzeville</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Boury</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Duday</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Moretto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Thomann</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Eco-friendly processes for the synthesis of amorphous calcium carbonate nanoparticles in ethanol and their stabilisation in aqueous media</article-title>. <source>Green Chem.</source> <volume>24</volume>, <fpage>1270</fpage>&#x2013;<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1039/d1gc03396d</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curtis</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Foster</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Miskovic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>C. S. B.</given-names>
</name>
<name>
<surname>Hewett</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Abbott</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Association of surgical skill assessment with clinical outcomes in cancer surgery</article-title>. <source>JAMA Surg.</source> <volume>155</volume> (<issue>7</issue>), <fpage>590</fpage>&#x2013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1001/jamasurg.2020.1004</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dang</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z. Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z. S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A facile and controllable method to <italic>in situ</italic> synthesize stable hydrophobic vaterite particles</article-title>. <source>Cryst. Res. Technol.</source> <volume>54</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/crat.201800243</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delierneux</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kouba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shanmughapriya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Potier-Cartereau</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Trebak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hempel</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mitochondrial calcium regulation of redox signaling in cancer</article-title>. <source>Cells</source> <volume>9</volume> (<issue>2</issue>), <fpage>432</fpage>. <pub-id pub-id-type="doi">10.3390/cells9020432</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Al-Lezami</surname>
<given-names>H. A. A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Green synthesis, characterization and application of calcium carbonate nanoparticles in the effective treatment of grey water for sustainable water management</article-title>. <source>J. Iran. Chem. Soc.</source> <volume>20</volume>, <fpage>1417</fpage>&#x2013;<lpage>1426</lpage>. <pub-id pub-id-type="doi">10.1007/s13738-023-02766-1</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Construction of pH-Sensitive nanovaccines encapsulating tumor cell lysates and immune adjuvants for breast cancer therapy</article-title>. <source>Small</source>, <fpage>2301420</fpage>. <pub-id pub-id-type="doi">10.1002/smll.202301420</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Metal-polyphenol-network coated CaCO<sub>3</sub> as pH-responsive nanocarriers toenable effective intratumoral penetration and reversal of multidrug resistance for augmented cancer treatments</article-title>. <source>Nano Res.</source> <volume>13</volume> (<issue>11</issue>), <fpage>3057</fpage>&#x2013;<lpage>3067</lpage>. <pub-id pub-id-type="doi">10.1007/s12274-020-2972-9</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>Z. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Chemical modulation of glucose metabolism with a fluorinated CaCO<sub>3</sub> nanoregulator can potentiate radiotherapy by programming antitumor immunity</article-title>. <source>ACS Nano</source> <volume>16</volume> (<issue>9</issue>), <fpage>13884</fpage>&#x2013;<lpage>13899</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.2c02688</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisner</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Neher</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Taschenberger</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Physiology of intracellular calcium buffering</article-title>. <source>Physiol. Rev.</source> <volume>103</volume>, <fpage>2767</fpage>&#x2013;<lpage>2845</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00042.2022</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbaz</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rannard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>T. O.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Controlled synthesis of calcium carbonate nanoparticles and stimuli-responsive multi-layered nanocapsules for oral drug delivery</article-title>. <source>Int. J. Pharm.</source> <volume>574</volume>, <fpage>118866</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2019.118866</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Febrida</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cahyanto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Herda</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Muthukanan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Djustiana</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Faizal</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Synthesis and characterization of porous CaCO<sub>3</sub> vaterite particles by simple solution method</article-title>. <source>Materials</source> <volume>14</volume> (<issue>16</issue>), <fpage>4425</fpage>. <pub-id pub-id-type="doi">10.3390/ma14164425</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>T. A. T.</given-names>
</name>
<name>
<surname>Yusof</surname>
<given-names>L. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>
<italic>In vivo</italic> evaluation of anticancer effificacy of drug loaded cockle shell-derived aragonite nanoparticles</article-title>. <source>J. Biomed. Mater Res. B</source> <volume>107</volume>, <fpage>1898</fpage>&#x2013;<lpage>1907</lpage>.</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gbadenyan</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Adali</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bright</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sithole</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The investigation of reinforcement properties of nano-CaCO<sub>3</sub> synthesized from <italic>Achatina fulica</italic> snail shell through mechanochemical methods on epoxy nanocomposites</article-title>. <source>Nanocomposites</source> <volume>7</volume>, <fpage>79</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1080/20550324.2021.1936972</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gindele</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Steingrube</surname>
<given-names>L. V.</given-names>
</name>
<name>
<surname>Gebauer</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Generality of liquid precursor phases in gas diffusion-based calcium carbonate synthesis</article-title>. <source>CrystEngComm</source> <volume>23</volume>, <fpage>7938</fpage>&#x2013;<lpage>7943</lpage>. <pub-id pub-id-type="doi">10.1039/d1ce00225b</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glitsch</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Mechano-and pH-sensing convergence on Ca<sup>2&#x2b;</sup>-mobilising proteins-A recipe for cancer?</article-title> <source>Cell. Calcium</source> <volume>80</volume>, <fpage>38</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2019.03.010</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>F. H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A Glycosylated covalent organic framework equipped with BODIPY and CaCO<sub>3</sub> for synergistic tumor therapy</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source> <volume>59</volume> (<issue>41</issue>), <fpage>18042</fpage>&#x2013;<lpage>18047</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202008055</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Preparation and <italic>in-situ</italic> surface modification of CaCO<sub>3</sub> nanoparticles with calcium stearate in a microreaction system</article-title>. <source>Powder Technol.</source> <volume>356</volume>, <fpage>414</fpage>&#x2013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1016/j.powtec.2019.08.054</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Ferrous ions doped calcium carbonate nanoparticles potentiate chemotherapy by inducing ferroptosis</article-title>. <source>J. Control Release</source> <volume>348</volume>, <fpage>346</fpage>&#x2013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2022.06.002</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Smart responsive-calcium carbonate nanoparticles for dual-model cancer imaging and treatment</article-title>. <source>Ultrasonics</source> <volume>108</volume>, <fpage>106198</fpage>. <pub-id pub-id-type="doi">10.1016/j.ultras.2020.106198</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussein</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Husein</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ab-Ghani</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ab Ghani</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Ab. Rahman</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Synthesis and characterization of spherical calcium carbonate nanoparticles derived from cockle shells</article-title>. <source>Appl. Sci.</source> <volume>10</volume> (<issue>20</issue>), <fpage>7170</fpage>. <pub-id pub-id-type="doi">10.3390/app10207170</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ippolito</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hubner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Claypole</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gane</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Influence of the surface modification of calcium carbonate on polyamide 12 composites</article-title>. <source>Polym. (Basel)</source> <volume>12</volume>, <fpage>1295</fpage>. <pub-id pub-id-type="doi">10.3390/polym12061295</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Q. F.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Amorphous calcium carbonate cluster nanospheres in water-deficient organic solvents</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>61</volume> (<issue>47</issue>), <fpage>e202211254</fpage>. <pub-id pub-id-type="doi">10.1002/anie.202211254</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaiping</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wanfen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Siying</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hongzhou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Minghong</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Preparation of hydrophobic nano calcium carbonate and its application in EOR</article-title>. <source>IOP Conf. Ser. Earth Environ. Sci.</source> <volume>1152</volume>, <fpage>012012</fpage>. <pub-id pub-id-type="doi">10.1088/1755-1315/1152/1/012012</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanwal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Uzair</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sajjad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Samin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ali Khan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Khan Leghari</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Synthesis and characterization of carbon dots coated CaCO<sub>3</sub> nanocarrier for levofloxacin against multidrug resistance extended-spectrum beta-lactamase escherichia coli of urinary tract infection origin</article-title>. <source>Microb. Drug Resist</source> <volume>28</volume>, <fpage>106</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1089/mdr.2020.0621</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kashyap</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Solanki</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ruokolainen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kesari</surname>
<given-names>K. K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Smart nanomaterials in cancer theranostics: challenges and opportunities</article-title>. <source>ACS Omega</source> <volume>8</volume> (<issue>16</issue>), <fpage>14290</fpage>&#x2013;<lpage>14320</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.2c07840</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Din</surname>
<given-names>F. U.</given-names>
</name>
<name>
<surname>Abdoul Razak</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Nawaz</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Cisplatin and oleanolic acid Co-loaded pH-sensitive CaCO<sub>3</sub> nanoparticles for synergistic chemotherapy</article-title>. <source>RSC Adv.</source> <volume>12</volume>, <fpage>14808</fpage>&#x2013;<lpage>14818</lpage>. <pub-id pub-id-type="doi">10.1039/d2ra00742h</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Jamil</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rashid</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Janjua</surname>
<given-names>M. R. S. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Agar and egg shell derived calcium carbonate and calcium hydroxide nanoparticles: synthesis, characterization and applications</article-title>. <source>Chem. Phys. Lett.</source> <volume>732</volume>, <fpage>136662</fpage>. <pub-id pub-id-type="doi">10.1016/j.cplett.2019.136662</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cu&#x2013;ferrocene-functionalized CaO<sub>2</sub> nanoparticles to enable tumor-specific synergistic therapy with GSH depletion and calcium overload</article-title>. <source>Adv. Sci.</source> <volume>8</volume> (<issue>14</issue>), <fpage>e2100241</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202100241</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>Mintz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Achilefu</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Calcium carbonate nanoparticles stimulate cancer cell reprogramming to suppress tumor growth and invasion in an organ-on-a-chip system</article-title>. <source>Sci. Rep-UK</source> <volume>11</volume>, <fpage>9246</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-88687-6</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jo</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Effect of surface modification of CaCO<sub>3</sub> nanoparticles by a silane coupling agent methyltrimethoxysilane on the stability of foam and emulsion</article-title>. <source>J. Ind. Eng. Chem.</source> <volume>74</volume>, <fpage>63</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.jiec.2019.02.002</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>C. Q.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Di</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S. l.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Surface modification of calcium carbonate: A review of theories, methods and applications</article-title>. <source>J. Cent. South Univ.</source> <volume>28</volume>, <fpage>2589</fpage>&#x2013;<lpage>2611</lpage>. <pub-id pub-id-type="doi">10.1007/s11771-021-4795-6</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Lingland</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Westr&#xf8;m</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>A novel single-step-labeled 212Pb-CaCO<sub>3</sub> microparticle for internal alpha therapy: preparation, stability, and preclinical data from mice</article-title>. <source>Materials</source> <volume>14</volume> (<issue>23</issue>), <fpage>7130</fpage>. <pub-id pub-id-type="doi">10.3390/ma14237130</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020b</year>). <article-title>CaCO<sub>3</sub> nanoparticles pH-sensitively induce blood coagulation as a potential strategy for starving tumor therapy</article-title>. <source>J. Mater Chem. B</source> <volume>8</volume>, <fpage>1223</fpage>&#x2013;<lpage>1234</lpage>. <pub-id pub-id-type="doi">10.1039/c9tb02684c</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Muhammad</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Studies on the properties of modified heavy calcium carbonate and SBS composite modified asphalt</article-title>. <source>Constr. Build. Mater</source> <volume>218</volume>, <fpage>413</fpage>&#x2013;<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1016/j.conbuildmat.2019.05.139</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020a</year>). <article-title>Porous calcite CaCO<sub>3</sub> microspheres: preparation, characterization and release behavior as doxorubicin carrier</article-title>. <source>Colloid Surf. B</source> <volume>186</volume>, <fpage>110720</fpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2019.110720</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2020c</year>). <article-title>Nanoenabled intracellular calcium bursting for safe and efficient reversal of drug resistance in tumor cells</article-title>. <source>Nano Lett.</source> <volume>20</volume> (<issue>11</issue>), <fpage>8102</fpage>&#x2013;<lpage>8111</lpage>. <pub-id pub-id-type="doi">10.1021/acs.nanolett.0c03042</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2021c</year>). <article-title>CaCO<sub>3</sub> nanoparticles incorporated with KAE to enable amplified calcium overload cancer therapy</article-title>. <source>Biomaterials</source> <volume>277</volume>, <fpage>121080</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.121080</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2021d</year>). <article-title>A mineralization strategy based on T-cell membrane coated CaCO<sub>3</sub> nanoparticles against breast cancer and metastasis</article-title>. <source>Mater Chem. Front.</source> <volume>5</volume>, <fpage>5738</fpage>&#x2013;<lpage>5745</lpage>. <pub-id pub-id-type="doi">10.1039/d1qm00464f</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>PolyTLR7/8a-conjugated, antigen-trapping gold nanorods elicit anticancer immunity against abscopal tumors by photothermal therapy-induced <italic>in situ</italic> vaccination</article-title>. <source>Biomaterials</source> <volume>275</volume>, <fpage>120921</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.120921</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Multimode CaCO<sub>3</sub>/pneumolysin antigen delivery systems for inducing efficient cellular immunity for anti-tumor immunotherapy</article-title>. <source>Chem. Eng. J.</source> <volume>420</volume>, <fpage>129746</fpage>. <pub-id pub-id-type="doi">10.1016/j.cej.2021.129746</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Polyethylenimine-CO<sub>2</sub> adduct templated CaCO<sub>3</sub> nanoparticles as anticancer drug carrier</article-title>. <source>Cancer Nanotechnol.</source> <volume>186</volume>, <fpage>7</fpage>. <pub-id pub-id-type="doi">10.1186/s12645-023-00156-z</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>X. X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z. L.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Lipid-coated CaCO<sub>3</sub>-PDA nanoparticles as a versatile nanocarrier to enable pH-responsive dual modal imaging-guided combination cancer therapy</article-title>. <source>J. Mat. Chem. B</source>, <fpage>10</fpage>.</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Foda</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Intracellular Ca<sup>2&#x2b;</sup> cascade guided by NIR-II photothermal switch for specific tumor therapy</article-title>. <source>i Sci.</source> <volume>23</volume> (<issue>5</issue>), <fpage>101049</fpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2020.101049</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Nano-CaCO<sub>3</sub> synthesis by tangential jet from carbide slag</article-title>. <source>Mater Res. Express</source> <volume>8</volume> (<issue>9</issue>), <fpage>095005</fpage>. <pub-id pub-id-type="doi">10.1088/2053-1591/ac2285</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Giorgi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Galluzzi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pinton</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Ca<sup>2&#x2b;</sup> fuxes and cancer</article-title>. <source>Mol. Cell.</source> <volume>78</volume> (<issue>6</issue>), <fpage>1055</fpage>&#x2013;<lpage>1069</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2020.04.017</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mkhize</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Onwubu</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Mlambo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mdluli</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>An <italic>in vitro</italic> assessment of the acid resistance characteristics of nanohydroxyapatite/silica biocomposite synthesized using mechanochemistry</article-title>. <source>J. Nanomater</source> <volume>2021</volume>, <fpage>1</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1155/2021/4438100</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niu</surname>
<given-names>Y. Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Aymonier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fermani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kralj</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Falini</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Calcium carbonate: controlled synthesis, surface functionalization, and nanostructured materials</article-title>. <source>Chem. Soc. Rev.</source> <volume>51</volume>, <fpage>7883</fpage>&#x2013;<lpage>7943</lpage>. <pub-id pub-id-type="doi">10.1039/d1cs00519g</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novoselova</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>German</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Abakumova</surname>
<given-names>T. O.</given-names>
</name>
<name>
<surname>Perevoschikov</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Sergeeva</surname>
<given-names>O. V.</given-names>
</name>
<name>
<surname>Nesterchuk</surname>
<given-names>M. V.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Multifunctional nanostructured drug delivery carriers for cancer therapy: multimodal imaging and ultrasound-induced drug release</article-title>. <source>Colloid surfaces B</source> <volume>200</volume>, <fpage>111576</fpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2021.111576</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pei</surname>
<given-names>Z. F.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Bioactive inorganic nanomaterials for cancer theranostics</article-title>. <source>Chem. Soc. Rev.</source> <volume>52</volume>, <fpage>2031</fpage>&#x2013;<lpage>2081</lpage>. <pub-id pub-id-type="doi">10.1039/d2cs00352j</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rez-Villarejo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Takabait</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mahtout</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Carrasco-Hurtado</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Eliche-Quesada</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>S&#xe1;nchez-Soto</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Synthesis of vaterite CaCO<sub>3</sub> as submicron and nanosized particles using inorganic precursors and sucrose in aqueous medium</article-title>. <source>Ceram. Int.</source> <volume>44</volume> (<issue>5</issue>), <fpage>5291</fpage>&#x2013;<lpage>5296</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceramint.2017.12.142</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Persano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nobile</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Piccirillo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gigli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Leporatti</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Monodisperse and nanometric-sized calcium carbonate particles synthesis optimization</article-title>. <source>Nanomaterials</source> <volume>12</volume>, <fpage>1494</fpage>. <pub-id pub-id-type="doi">10.3390/nano12091494</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piras</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Borggraeve</surname>
<given-names>W. M. D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Ball milling: A green technology for the preparation and functionalisation of nanocellulose derivatives</article-title>. <source>Nanoscale Adv.</source> <volume>1</volume>, <fpage>937</fpage>&#x2013;<lpage>947</lpage>. <pub-id pub-id-type="doi">10.1039/c8na00238j</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popova</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Poletaeva</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pyshnaya</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pyshnyi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dmitrienko</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Designing pH-dependent systems based on nanoscale calcium carbonate for the delivery of an antitumor drug</article-title>. <source>Nanomaterials-Basel</source> <volume>11</volume> (<issue>11</issue>), <fpage>2794</fpage>. <pub-id pub-id-type="doi">10.3390/nano11112794</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Preksha</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Simona</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Stuti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Panchal</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dave</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Calcium carbonate nano- and microparticles: synthesis methods and biological applications</article-title>. <source>Bio Tech.</source> <volume>11</volume>, <fpage>457</fpage>. <pub-id pub-id-type="doi">10.1007/s13205-021-02995-2</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prihanto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Muryanto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vaquer</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Schmahl</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jamari</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>In-depth knowledge of the low-temperature hydrothermal synthesis of nanocrystalline hydroxyapatite from waste green mussel shell (Perna Viridis)</article-title>. <source>EnvironTechnol</source>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1080/09593330.2023.2173087</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Artificial nanotargeted cells with stable photothermal performance for multimodal imaging-guided tumor-specific therapy</article-title>. <source>ACS Nano</source> <volume>14</volume> (<issue>10</issue>), <fpage>12652</fpage>&#x2013;<lpage>12667</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.0c00771</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>Q. D.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>W. F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B. Q.</given-names>
</name>
<name>
<surname>Shuai</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Flash nanoprecipitation fabrication of PEI@Amorphous calcium carbonate hybrid nanoparticles for siRNA delivery</article-title>. <source>Macromol. Biosci.</source> <volume>7</volume>, <fpage>2300085</fpage>. <pub-id pub-id-type="doi">10.1002/mabi.202300085</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rinu</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Queen</surname>
<given-names>M. A. J.</given-names>
</name>
<name>
<surname>Udhaya</surname>
<given-names>P. A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Synthesis, structural characterization and antibacterial applications of calcium nanoparticles</article-title>. <source>J. Adv. Sci. Res.</source> <volume>11</volume> (<issue>1</issue>), <fpage>83</fpage>&#x2013;<lpage>87</lpage>.</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruysscher</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Niedermann</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Burnet</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>Siva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A. W. M.</given-names>
</name>
<name>
<surname>Hegi-Johnson</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Radiotherapy toxicity</article-title>. <source>Nat. Rev. Dis. Prim.</source> <volume>5</volume> (<issue>1</issue>), <fpage>13</fpage>. <pub-id pub-id-type="doi">10.1038/s41572-019-0064-5</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>J. Z.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Preparation and the effect of surface-functionalized calcium carbonate nanoparticles on asphalt binder</article-title>. <source>Appl. Sci.</source> <volume>10</volume>, <fpage>91</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.3390/app10010091</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X. X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Karges</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>A pH-responsive iridium (III) two-photon photosensitizer loaded CaCO<sub>3</sub> nanoplatform for combined Ca<sup>2&#x2b;</sup> overload and photodynamic therapy</article-title>. <source>Inorg. Chem. Front.</source> <volume>9</volume>, <fpage>4171</fpage>&#x2013;<lpage>4183</lpage>. <pub-id pub-id-type="doi">10.1039/d2qi00951j</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Calcification-based cancer diagnosis and therapy</article-title>. <source>Chem. Med. Chem.</source> <volume>17</volume> (<issue>4</issue>), <fpage>e202100339</fpage>. <pub-id pub-id-type="doi">10.1002/cmdc.202100339</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Som</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Raliya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Akers</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ippolito</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Singamaneni</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth <italic>in vivo</italic>
</article-title>. <source>Nanoscale</source> <volume>8</volume>, <fpage>12639</fpage>&#x2013;<lpage>12647</lpage>. <pub-id pub-id-type="doi">10.1039/c5nr06162h</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Applicability and theoretical calculation of enzymatic calcium carbonate precipitation for sand improvement</article-title>. <source>Geomicrobiol. J.</source> <volume>37</volume>, <fpage>389</fpage>&#x2013;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1080/01490451.2019.1710625</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ferlay</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Siegel</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Laversanne</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Soerjomataram</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Jemal</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J. Clin.</source> <volume>71</volume> (<issue>3</issue>), <fpage>209</fpage>&#x2013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21660</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Castanheira</surname>
<given-names>E. M. S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Functionalized liposome and albumin-based systems as carriers for poorly water-soluble anticancer drugs: an updated review</article-title>. <source>Biomedicines</source> <volume>10</volume> (<issue>2</issue>), <fpage>486</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines10020486</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tinawi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Disorders of calcium metabolism: hypocalcemia and hypercalcemia</article-title>. <source>Cureus</source> <volume>13</volume> (<issue>1</issue>), <fpage>e12420</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.12420</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torgbo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sukyai</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Watthanasakphuban</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kamonsutthipaijit</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Filter cake-derived calcium carbonate polymorphs from sugar refinery for hydroxyapatite production as a sustainable material for biomedical application</article-title>. <source>Ceram. Int.</source> <volume>49</volume>, <fpage>23417</fpage>&#x2013;<lpage>23425</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceramint.2023.04.174</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trushina</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Borodina</surname>
<given-names>T. N.</given-names>
</name>
<name>
<surname>Belyakov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Antipina</surname>
<given-names>M. N.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Calcium carbonate vaterite particles for drug delivery: advances and challenges</article-title>. <source>Mater Today Adv.</source> <volume>14</volume>, <fpage>100214</fpage>. <pub-id pub-id-type="doi">10.1016/j.mtadv.2022.100214</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vavaev</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Novoselova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shchelkunov</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>German</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Komlev</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Mokrousov</surname>
<given-names>M. D.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>CaCO<sub>3</sub> nanoparticles coated with alternating layers of poly-l-arginine hydrochloride and Fe<sub>3</sub>O<sub>4</sub> nanoparticles as navigable drug carriers and hyperthermia agents</article-title>. <source>ACS Appl. Nano Mater</source> <volume>5</volume>, <fpage>2994</fpage>&#x2013;<lpage>3006</lpage>. <pub-id pub-id-type="doi">10.1021/acsanm.2c00338</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidallon</surname>
<given-names>M. L. P.</given-names>
</name>
<name>
<surname>Douek</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Quek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McLiesh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kaslin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tabor</surname>
<given-names>R. F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Gas&#x2010;generating, pH&#x2010;responsive calcium carbonate hybrid particles with biomimetic coating for contrast&#x2010;enhanced ultrasound imaging</article-title>. <source>Part Part Syst. Char</source> <volume>37</volume> (<issue>2</issue>), <fpage>1900471</fpage>. <pub-id pub-id-type="doi">10.1002/ppsc.201900471</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vikulina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Voronin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fakhrullin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Vinokurov</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mesoporous additive-free vaterite CaCO<sub>3</sub> crystals of untypical sizes: from submicron to giant</article-title>. <source>Mater Des.</source> <volume>197</volume>, <fpage>109220</fpage>. <pub-id pub-id-type="doi">10.1016/j.matdes.2020.109220</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>&#x3c;p&#x3e;Size-Controlled preparation and behavior study of phospholipid&#x2013;calcium carbonate hybrid nanoparticles&#x3c;/p&#x3e;</article-title>. <source>Intern. J. Nanomed</source> <volume>15</volume>, <fpage>4049</fpage>&#x2013;<lpage>4062</lpage>. <pub-id pub-id-type="doi">10.2147/ijn.s237156</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z. L.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Coordination polymer-coated CaCO<sub>3</sub> reinforces radiotherapy by reprogramming the immunosuppressive metabolic microenvironment</article-title>. <source>Adv. Mater</source> <volume>34</volume> (<issue>3</issue>), <fpage>2106520</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202106520</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q. N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2023a</year>). <article-title>Nanomaterials mediated multimodal combined treatment for cancer</article-title>. <source>Mini-Rev Med. Chem.</source> <volume>23</volume>, <fpage>1623</fpage>&#x2013;<lpage>1641</lpage>. <pub-id pub-id-type="doi">10.2174/1389557523666230117103157</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2023b</year>). <article-title>NIR absorptive croconic acid/quercetin/CaO<sub>2</sub>nanoplatform for tumor calcium overload therapy combined mild photothermal therapy</article-title>. <source>Mater. Sci. Eng. C-Materials Biol. Appl.</source> <volume>149</volume>, <fpage>213418</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioadv.2023.213418</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J. X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Inorganic nanomaterials with rapid clearance for biomedical applications</article-title>. <source>Chem. Soc. Rev.</source> <volume>50</volume> (<issue>15</issue>), <fpage>8669</fpage>&#x2013;<lpage>8742</lpage>. <pub-id pub-id-type="doi">10.1039/d0cs00461h</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Worsley</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Veale</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Mayne</surname>
<given-names>E. S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The acidic tumour microenvironment: manipulating the immune response to elicit escape</article-title>. <source>Hum. Immunol.</source> <volume>83</volume> (<issue>5</issue>), <fpage>399</fpage>&#x2013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1016/j.humimm.2022.01.014</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nhung</surname>
<given-names>N. T. H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The influence of air nanobubbles on controlling the synthesis of calcium carbonate crystals</article-title>. <source>Colloids Surfaces A Physicochem. Eng. Aspects</source> <volume>15</volume> (<issue>21</issue>), <fpage>7437</fpage>. <pub-id pub-id-type="doi">10.3390/ma15217437</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Cancer statistics in China and United States, 2022: profiles, trends, and determinants</article-title>. <source>Chin. Med. J.</source> <volume>135</volume> (<issue>5</issue>), <fpage>584</fpage>&#x2013;<lpage>590</lpage>. <pub-id pub-id-type="doi">10.1097/cm9.0000000000002108</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>T. T.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022a</year>). <article-title>Synthesis of stable calcium carbonate nanoparticles for pH-responsive controlled drug release</article-title>. <source>Mater Lett.</source> <volume>333</volume>, <fpage>133635</fpage>. <pub-id pub-id-type="doi">10.1016/j.matlet.2022.133635</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>M. Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Foda</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022b</year>). <article-title>Activation of TRPV1 by capsaicin-loaded CaCO<sub>3</sub> nanoparticle for tumor-specific therapy</article-title>. <source>Biomaterials</source> <volume>284</volume>, <fpage>121520</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2022.121520</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kitahara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kusuda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Horise</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Masamune</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Current landscape of sonodynamic therapy for treating cancer</article-title>. <source>Cancers</source> <volume>13</volume> (<issue>24</issue>), <fpage>6184</fpage>. <pub-id pub-id-type="doi">10.3390/cancers13246184</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z. Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>Preparation of nano-sized calcium carbonate in solution mixing process</article-title>. <source>J. Cryst. Growth</source> <volume>571</volume>, <fpage>126247</fpage>. <pub-id pub-id-type="doi">10.1016/j.jcrysgro.2021.126247</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Polyprodrug nanomedicines: an emerging paradigm for cancer therapy</article-title>. <source>Adv. Mater</source> <volume>34</volume> (<issue>6</issue>), <fpage>2107434</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202107434</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>CaCO<sub>3</sub>-encapsulated Au nanoparticles modulate macrophages toward M1-like phenotype</article-title>. <source>ACS Appl. Bio Mater</source> <volume>4</volume> (<issue>4</issue>), <fpage>3214</fpage>&#x2013;<lpage>3223</lpage>. <pub-id pub-id-type="doi">10.1021/acsabm.0c01608</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>
<italic>In vivo</italic> tumor visualization through MRI off&#x2010;on switching of NaGdF<sub>4</sub>-CaCO<sub>3</sub> nanoconjugates</article-title>. <source>Adv. Mater.</source> <volume>31</volume>, <fpage>1901851</fpage>. <pub-id pub-id-type="doi">10.1002/adma.201901851</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Multifunctional nanoparticles codelivering doxorubicin and amorphous calcium carbonate preloaded with indocyanine green for enhanced chemo-photothermal cancer therapy</article-title>. <source>Inter J. Nanomed</source> <volume>18</volume>, <fpage>323</fpage>&#x2013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.2147/ijn.s394896</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Biomimetic calcium carbonate nanoparticles delivered IL-12 mRNA for targeted glioblastoma sono-immunotherapy by ultrasound-induced necroptosis</article-title>. <source>J. Nanobiotechnol</source> <volume>525</volume>, <fpage>20</fpage>.</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>Tumor microenvironment-responsive Cu/CaCO<sub>3</sub>-based nanoregulator for mitochondrial homeostasis disruption-enhanced chemodynamic/sonodynamic therapy</article-title>. <source>Small</source> <volume>18</volume>, <fpage>2204047</fpage>. <pub-id pub-id-type="doi">10.1002/smll.202204047</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Kai</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer</article-title>. <source>Int. J. Pharm.</source> <volume>636</volume>, <fpage>122844</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2023.122844</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>A multichannel Ca<sup>2&#x2b;</sup> nanomodulator for multilevel mitochondrial destruction-mediated cancer therapy</article-title>. <source>Adv. Mater,</source> <volume>33</volume> (<issue>15</issue>), <fpage>2007426</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202007426</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>G. Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Biodegradable Ca<sup>2&#x2b;</sup> nanomodulators activate pyroptosis through mitochondrial Ca<sup>2&#x2b;</sup> overload for cancer immunotherapy</article-title>. <source>Angew. Chem.</source> <volume>36</volume>, <fpage>61</fpage>. <pub-id pub-id-type="doi">10.1002/ange.202204904</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>W. Z.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy</article-title>. <source>Acta biomater.</source> <volume>145</volume>, <fpage>135</fpage>&#x2013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2022.03.051</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Hyaluronan derivative decorated calcium carbonate nanoparticle as a potential platform for breast cancer synergistic therapy via blood coagulation and drug delivery</article-title>. <source>J. Drug Deliv. Sci. Technol.</source> <volume>83</volume>, <fpage>104406</fpage>. <pub-id pub-id-type="doi">10.1016/j.jddst.2023.104406</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy</article-title>. <source>J. Nanobiotechnol</source> <volume>20</volume>, <fpage>188</fpage>. <pub-id pub-id-type="doi">10.1186/s12951-022-01392-y</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>
<italic>In situ</italic> generation of biocompatible amorphous calcium carbonate onto cell membrane to block membrane transport protein-A new strategy for cancer therapy via mimicking abnormal mineralization</article-title>. <source>J. Colloid Interface Sci.</source> <volume>541</volume>, <fpage>339</fpage>&#x2013;<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcis.2019.01.090</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>X. D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Nanomaterials in tumor immunotherapy: new strategies and challenges</article-title>. <source>Mol. Cancer</source> <volume>22</volume>, <fpage>94</fpage>. <pub-id pub-id-type="doi">10.1186/s12943-023-01797-9</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>